- Report
- October 2024
- 83 Pages
Global
From €4278EUR$4,850USD£3,758GBP
- Report
- September 2024
- 89 Pages
Global
From €4278EUR$4,850USD£3,758GBP
- Report
- August 2024
- 116 Pages
Global
From €3969EUR$4,500USD£3,487GBP
- Report
- January 2024
- 130 Pages
Global
From €3969EUR$4,500USD£3,487GBP
- Report
- July 2023
- 100 Pages
Global
From €4278EUR$4,850USD£3,758GBP
- Report
- June 2023
- 62 Pages
Global
From €1720EUR$1,950USD£1,511GBP
- Report
- August 2025
- 150 Pages
Global
From €2962EUR$3,358USD£2,602GBP
€3484EUR$3,950USD£3,061GBP
- Report
- February 2024
- 103 Pages
Global
From €3500EUR$4,251USD£3,182GBP
- Report
- November 2024
- 120 Pages
Global
From €3500EUR$4,251USD£3,182GBP
- Report
- May 2024
- 95 Pages
Global
From €3500EUR$4,251USD£3,182GBP
- Report
- February 2024
- 91 Pages
Global
From €3500EUR$4,251USD£3,182GBP
- Report
- February 2022
- 87 Pages
Global
From €3200EUR$3,886USD£2,910GBP
- Report
- January 2025
- 132 Pages
Global
From €838EUR$950USD£736GBP
- Report
- January 2025
- 132 Pages
Global
From €838EUR$950USD£736GBP
- Report
- January 2025
- 132 Pages
Global
From €838EUR$950USD£736GBP
- Book
- June 2020
- 198 Pages

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more